✦ LIBER ✦

671 Phase III study comparing AT (Adriamycin, Docetaxel) to FAC (Fluorouracil, Adriamycin, Cyclophosphamide) as first-line chemotherapy (CT) in patients with metastatic breast cancer (MBC)

✍ Scribed by M. Bontenbal; J.J. Braun; G.J. Creemers; A.C. de Boer; J.Th.P. Janssen; M.B.L. Leys; K.L.C. Schothorst; P.I.M. Schmitz; J.J. Bokma; C. Seynaeve

Book ID: 118620843
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 310 KB
Volume: 1
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(03)90702-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized open-label phase III multicen

Randomized open-label phase III multicenter trial comparing TAXOL®/doxorubicin (AT) versus 5-fluorouracil/doxorubicin and cyclophosphamide (FAC) as a first line treatment for patients with metastatic breast cancer

✍ Płuż;zańska, A.; Jassem, J.; Jelič, S.; Gorbunova, V.; Mrsič-Krmpotič, Z.; Berzi 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 152 KB